Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation

被引:26
作者
Brunner, G [1 ]
Reimbold, K [1 ]
Meissauer, A [1 ]
Schirrmacher, V [1 ]
Erkell, LJ [1 ]
机构
[1] German Canc Res Ctr, Tumor Immunol Program, Div Cellular Immunol, D-6900 Heidelberg, Germany
关键词
D O I
10.1006/excr.1997.3877
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasizing tumor cells invade host tissues by degrading extracellular matrix constituents. We report here that the highly sulfated glycosaminoglycans, heparin and heparan sulfate, as well as the sulfated polysaccharide, fucoidan, significantly enhanced tumor cell invasion in vitro into fibrin, the basement membrane extract, Matrigel, or through a basement membrane-like extracellular matrix. The enhancement of tumor cell invasion was due to a stimulation of the proteolytic cascade of plasminogen activation since the effect required plasminogen activation and was abolished by inhibitors of urokinase-type plasminogen activator (uPA) or plasmin. Sulfated polysaccharides enhanced five reactions of tumor-cell initiated plasminogen activation in a dose-dependent manner. They amplified plasminogen activation in culture supernatants up to 70-fold by stimulating (i) pro-uPA activation by plasmin and (ii) plasminogen activation by uPA. (iii) In addition, sulfated polysaccharides partially protected plasmin from inactivation by alpha(2)-antiplasmin. Sulfated polysaccharides also stimulated tumor-cell associated plasminogen activation, e.g., (iv) cell surface pro-uPA activation by plasmin and (v) plasminogen activation by cell surface uPA. These results suggest that sulfated glycosaminoglycans Liberated by tumor-cell mediated extracellular matrix degradation in vivo might amplify pericellular plasminogen activation and locally enhance tumor cell invasion in a positive feedback manner. (C) 1998 Academic Press.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 51 条
[1]   INTERACTION OF HEPARIN WITH PLASMINOGEN ACTIVATORS AND PLASMINOGEN - EFFECTS ON THE ACTIVATION OF PLASMINOGEN [J].
ANDRADEGORDON, P ;
STRICKLAND, S .
BIOCHEMISTRY, 1986, 25 (14) :4033-4040
[2]   INVOLVEMENT OF BOTH HEPARANASE AND PLASMINOGEN-ACTIVATOR IN LYMPHOMACELL-MEDIATED DEGRADATION OF HEPARAN-SULFATE IN THE SUBENDOTHELIAL EXTRACELLULAR-MATRIX [J].
BARNER, M ;
MAYER, M ;
SCHIRRMACHER, V ;
VLODAVSKY, I .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (02) :299-306
[4]  
BRUNNER G, 1994, BLOOD COAGUL FIBRIN, V5, P625
[5]   INDUCTION OF UROKINASE ACTIVITY AND MALIGNANT PHENOTYPE IN BLADDER-CARCINOMA CELLS AFTER TRANSFECTION OF THE ACTIVATED HA-RAS ONCOGENE [J].
BRUNNER, G ;
POHL, J ;
ERKELL, LJ ;
RADLERPOHL, A ;
SCHIRRMACHER, V .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (02) :139-144
[6]  
CONESE M, 1995, BIOL CHEM H-S, V376, P143
[7]  
CRISSMAN JD, 1988, CANCER RES, V48, P4065
[8]  
DABBOUS MK, 1986, CLIN EXP METASTAS, V4, P141
[9]   PLASMINOGEN ACTIVATOR FROM CELLS TRANSFORMED BY AN ONCOGENIC VIRUS - INHIBITORS OF THE ACTIVATION REACTION [J].
DANO, K ;
REICH, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 566 (01) :138-151
[10]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266